Imfinzi wins breakthrough therapy designation
AstraZeneca and MedImmune, have today announced that the US Food…
AstraZeneca and MedImmune, have today announced that the US Food and Drug Administration has granted breakthrough therapy designation for Imfinzi for the treatment of patients with locally-advanced, unresectable non-small cell lung cancer...